It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
COVID-19 Rapid Evidence Reviews
Toggle navigation
New Search
SK Repository
About
Help
Your Cart:
0
items
Refine Search
Refine Search
Revise search
Search
Document Type
Apply
Evidence Search Report
Rapid Review
Table
2
Research Team
Apply
EOC
2
Epidemiology & Modelling
2
Laboratory
4
Status
Apply
5. Updated review
6
3. Completed
2
Category
Apply
Administration
2
Clinical Management
2
Clinical Presentation
Diagnostics
2
Epidemiology
10
Healthcare Services
2
Infection Prevention and Control
12
Subject
Apply
Antibodies
4
Asymptomatic
2
Cancer
Chemotherapy
2
Clinical Presentation
5
Comorbidities
Critical Care
3
Health Planning
3
Immunity
6
Infection Prevention and Control
4
Long Covid
5
Modeling
1
More
Population
Apply
All
Advanced Search
All Records
All
Other
Clinical Presentation
Comorbidities
Transmission
Cancer
Rapid Review
Evidence Search Report
Sorted by
Newest
Sort by Relevance
Sort by Research Question / Title
Sort by Oldest
Table View
List View
Citation View
Expand all
Collapse all
Select All
8 records – page 1 of 1.
Prev
Next
Date
Research Question / Title
Unique ID
Research Team
January 22, 2021
What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update]
EOC062201v2 RR
EOC
January 4, 2021
What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update]
EOC062201v2-01 ESR
EOC
May 22, 2020
What is the relationship between antibody development and viral shedding and infectiousness? [Update]
LAB041601v2-01 ESR
Laboratory
May 19, 2020
What are the risk factors for severity and death associated with COVID-19?
EPM050901 RR
Epidemiology & Modelling
May 19, 2020
What is the relationship between antibody development and viral shedding and infectiousness? [Update]
LAB041601v2 RR
Laboratory
May 12, 2020
What are the risk factors for severity and death associated with COVID-19?
EPM050901-01 ESR
Epidemiology & Modelling
May 8, 2020
What proportion of disease transmission is due to asymptomatic, pre-symptomatic and symptomatic cases? [Update]
LAB040701v2 RR
Laboratory
May 8, 2020
What proportion of disease transmission is due to asymptomatic, pre-symptomatic and symptomatic cases? [Update]
LAB040701v2-01 ESR
Laboratory
8 records – page 1 of 1.
Prev
Next